The Impact of Particulate Matter 2.5 (PM2.5) Exposure on the Increased Incidence and Exacerbation of Allergic Rhinitis in the Pediatric Population: A Literature Review

Abstract

Air pollution, particularly exposure to Particulate Matter 2.5 (PM2.5), represents a significant threat to global health, with pronounced effects on the respiratory system. Children constitute the most vulnerable population due to anatomical characteristics, elevated respiratory rates, and underdeveloped immune systems. This literature review analyzes and synthesizes recent studies on the impact of PM2.5 exposure on the incidence and exacerbation of allergic rhinitis in children, with a focus on cellular pathomechanisms and management strategies. Evidence indicates that PM2.5 particles can directly compromise the nasal mucosal epithelial barrier and function as adjuvants, initiating inflammatory cascades through the activation of Toll-Like Receptors (TLRs). This activation results in hyperactivation of the T-helper 2 (Th2) pathway, leading to increased production of pro-inflammatory cytokines, Immunoglobulin E (IgE), and leukotrienes. Additionally, PM2.5 impairs anti-viral immune responses, sustains chronic inflammation, and heightens susceptibility to co-infections in children. Largescale cohort studies have demonstrated that prolonged PM2.5 exposure is associated with a higher incidence of new-onset allergic rhinitis and the aggravation of hyperreactivity symptoms, including persistent nasal congestion. In light of the substantial inflammatory burden, effective management of allergic rhinitis in the context of air pollution necessitates comprehensive treatment strategies. Management should extend beyond antihistamine monotherapy to include environmental interventions such as HEPA air purifiers and respiratory masks, mechanical removal of particulates through saline nasal irrigation, and escalation of pharmacotherapy with intranasal corticosteroids to achieve optimal clinical outcomes.